Jan Vilsvik

Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-Up

Stein Sundstrøm, Roy M. Bremnes, Stein Kaasa et al. · Journal of Clinical Oncology · 2002 · 504 citations

Medicine, Oncology, Pharmacology +9

Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial

Andreas Hermes, Bengt Bergman, Roy M. Bremnes et al. · Journal of Clinical Oncology · 2008 · 167 citations · Full text

Medicine, Oncology, Pharmacology +12

Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

Christian von Plessen, Bengt Bergman, Olga Andresen et al. · British Journal of Cancer · 2006 · 157 citations · Full text

Medicine, Oncology, Pharmacology +16

Multicenter Phase II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Cancer

Roy M. Bremnes, Stein Sundstrøm, Jan Vilsvik et al. · Journal of Clinical Oncology · 2001 · 45 citations

Medicine, Oncology, Radiation Oncology +10

The effect of beclomethasone dipropionate aerosol on allergen induced nasal stenosis

Jan Vilsvik, ARNE OLAV JENSSEN, R. A. Walstad · Clinical & Experimental Allergy · 1975 · 44 citations

Life Sciences, Immunology, Pharmacology +17